P3 Health Partners (PIII) Cash from Financing Activities (2021 - 2025)

P3 Health Partners (PIII) has reported Cash from Financing Activities for 5 consecutive years, with $12.9 million the latest figure, recorded in Q4 2025.

• Cash from Financing Activities for Q4 2025 came in at $12.9 million, down 61.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $72.8 million (down 26.28% YoY), and the FY2025 annual result was $72.8 million, down 26.28% from the prior year.
• Cash from Financing Activities was $12.9 million for Q4 2025 at P3 Health Partners, down from $14.7 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $87.2 million in Q2 2023 and troughed at -$2.5 million in Q3 2024.
• Average Cash from Financing Activities over 5 years is $15.6 million, with a median of $12.5 million recorded in 2021.
• Year-over-year, Cash from Financing Activities tumbled 5331.07% in 2022 and surged 7134.38% in 2023.
• Over 5 years, Cash from Financing Activities stood at -$22587.0 in 2021, then surged by 66509.88% to $15.0 million in 2022, then sank by 105.6% to -$840000.0 in 2023, then surged by 4113.93% to $33.7 million in 2024, then slumped by 61.82% to $12.9 million in 2025.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were $12.9 million in Q4 2025, $14.7 million in Q3 2025, and $14.6 million in Q2 2025.